HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin C F Fone Selected Research

DR-4004

8/2002DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin C F Fone Research Topics

Disease

16Schizophrenia (Dementia Praecox)
10/2020 - 09/2008
7Hypothermia
10/2020 - 02/2002
7Memory Disorders (Memory Loss)
07/2013 - 12/2003
5Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2009 - 02/2005
4Cognitive Dysfunction
05/2020 - 09/2010
4Neurobehavioral Manifestations
02/2016 - 09/2010
3Hyperthermia
02/2011 - 02/2004
2Alzheimer Disease (Alzheimer's Disease)
10/2020 - 09/2008
2Mental Disorders (Mental Disorder)
01/2019 - 08/2008
2Pain (Aches)
08/2007 - 07/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020
1Weight Loss (Weight Reduction)
10/2020
1Neurodevelopmental Disorders
10/2020
1Virus Diseases (Viral Diseases)
10/2020
1Brain Diseases (Brain Disorder)
05/2020
1Autism Spectrum Disorder
05/2020
1Autistic Disorder (Autism)
01/2019
1Body Weight (Weight, Body)
03/2012
1Psychotic Disorders (Schizoaffective Disorder)
06/2009
1Seizures (Absence Seizure)
02/2004
1Serotonin Syndrome (Syndrome, Serotonin)
02/2002

Drug/Important Bio-Agent (IBA)

8Dopamine (Intropin)FDA LinkGeneric
11/2016 - 08/2005
6Antipsychotic Agents (Antipsychotics)IBA
02/2016 - 08/2008
4serotonin 6 receptorIBA
10/2012 - 12/2003
4N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
02/2011 - 02/2002
3Serotonin (5 Hydroxytryptamine)IBA
11/2016 - 04/2002
3Phencyclidine (Angel Dust)IBA
06/2014 - 09/2010
3Methylphenidate (Ritalin)FDA LinkGeneric
12/2009 - 02/2005
3Amphetamine (Amfetamine)FDA LinkGeneric
12/2009 - 02/2005
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2020 - 05/2020
2CytokinesIBA
10/2020 - 01/2018
2Oxytocin (Pitocin)FDA LinkGeneric
10/2020 - 01/2019
2Dopamine Receptors (Dopamine Receptor)IBA
02/2016 - 06/2009
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2009 - 02/2005
1LigandsIBA
10/2020
1Memantine (Namenda)FDA Link
10/2020
1Cholinesterases (Cholinesterase)IBA
10/2020
1Poly I-CIBA
10/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2020
1NeuropeptidesIBA
01/2019
15-HT1B Serotonin ReceptorIBA
11/2016
1mephedroneIBA
11/2016
15-HT1A Serotonin ReceptorIBA
11/2016
1cariprazineIBA
02/2016
1gamma-Aminobutyric Acid (GABA)IBA
05/2014
1Pharmaceutical PreparationsIBA
05/2014
1KetamineFDA LinkGeneric
05/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1Vesicular Glutamate Transport Protein 1IBA
01/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
07/2013
1Sirolimus (Rapamycin)FDA Link
10/2012
1Therapeutic UsesIBA
05/2012
1N- (4- methoxy- 3- (4- methylpiperazin- 1- yl)phenyl)- 1,2- dihydro- 3- H- benzo(e)indole- 3- carboxamideIBA
03/2012
1metabotropic glutamate receptor 2IBA
03/2011
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
03/2011
1LY 379268IBA
03/2011
1Dopamine D3 ReceptorsIBA
09/2010
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2010
1Clozapine (Clozaril)FDA LinkGeneric
09/2010
1N- (4- (2- (8- cyano- 1,3a,4,9b- tetrahydro(1)benzopyrano(3,4- c)pyrrol- 2(3H)- yl)ethyl)phenyl)acetamideIBA
09/2010
1vanoxerine (I 893)IBA
12/2009
1Guanfacine (Tenex)FDA LinkGeneric
12/2009
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
12/2009
1Fluoxetine (Prozac)FDA LinkGeneric
11/2009
1Biomarkers (Surrogate Marker)IBA
08/2008
1SB 271046IBA
08/2007
1AminesIBA
07/2007
1SLI381IBA
07/2007
1Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2007
1Cholinergic Agents (Cholinergics)IBA
02/2004
1Dopamine D2 Receptor AntagonistsIBA
08/2002
1RacloprideIBA
08/2002
1DR-4004IBA
08/2002
1CorticosteroneIBA
04/2002

Therapy/Procedure

5Therapeutics
01/2019 - 09/2008
1Oral Administration
02/2005